The pharmaceutical industry has gone through radical changes in the last years across the globe. In Europe, the pandemic has underlined the importance of a unified Europe and a strong, innovative ecosystem to address the major health challenges. With advancements in technology and policy initiatives, the pharmaceutical manufacturing landscape is further transforming.
This 24-hour event organized by and for the ISPE Emerging Leaders gives students and recent graduates the unique opportunity to divulge knowledge in an innovative situation and network with senior industry experts.
This year’s focus is based on manufacturing operations from a Pharma 4.0™ perspective. The different groups gathered have to make their companies the most attractive to the investors by establishing a business case for a digital transformation project. The best takeaways from this opportunity are learning, networking, and having fun. We are excited about tomorrow's presentations!
In the next decade, we will experience more progress than in the past 100 years combined, as technology reshapes health and material sciences, energy, transportation, and a wide range of other industries and domains.
During #ISPEEU22, Paul Rutten, Principal, McKinsey & Company, discussed technologies that fuel the 4th industrial revolution as well as the impact of the upcoming bio revolution.
Watch Now: Hear some thoughts on quality risk management from Richard Denk, Senior Consultant Aseptic Processing & Containment, SKAN AG, during the #ISPEEU22 Regulatory Panel A: Panel Discussion with Regulators on Sustainability, Annex 1 Implementation, Good Engineering Practice.
Teresa Minero, Founder & CEO, LifeBee #ISPEEU22 Programme Chair posed this question during the Regulatory Panel: Panel Discussion with Regulators on Digital Transformation.
Watch this clip to hear from featured panelist David Churchward, Global Head Sterility Assurance, Cell and Gene Technologies, Lonza.